Chelikam Nikhila, Vyas Vandit, Dondapati Lavanya, Iskander Beshoy, Patel Ghanshyam, Jain Siddhant, Singla Tanvi, Bombaywala Ali, Zarrate Daniel, Debnath Neha, Jain Nitesh K, Peela Appala Suman, Patel Urvish K, Sharma Amit
Clinical Research, Icahn School of Medicine at Mount Sinai, New York, USA.
Internal Medicine, Surat Municipal Institute of Medical Education and Research, Surat, IND.
Cureus. 2022 Jul 19;14(7):e27016. doi: 10.7759/cureus.27016. eCollection 2022 Jul.
Substance use disorders (SUDs) are considered to be a major risk factor for cardiovascular disorders (CVDs). In 2019, as per the National Drug Use and Health Survey (NSDUH), 20.4 million American adults suffered from a substance use disorder. The main purpose of this study is to determine the prevalence of several SUDs (cigarette smoking, cigar, smokeless tobacco, marijuana, cocaine/heroin/methamphetamine, and injectable illegal drug) amongst patients diagnosed with various CVDs (angina pectoris, myocardial infarction, and coronary heart disease).
This is a retrospective cross-sectional study carried out using the National Health and Nutrition Examination Survey (NHANES) database from 2013 to 2018, and respondents with CVDs were recognized using questionnaires. Different SUDs (active history) were identified amongst the adult population with a history of CVDs and without CVDs. Univariate analysis was performed using chi-square and unpaired t-test/Mann-Whitney test to identify characteristics of respondents with CVDs and mix effect multivariable logistic regression models were generated to find the prevalence of SUDs amongst the CVD population. Datasets were analyzed using Statistical Analysis System (SAS) software, and the p-value of < 0.05 was considered statistically significant.
Of the 263465 respondents, 7.90% respondents were diagnosed with CVDs and were noted to be in older age group (median age: 69 years). CVDs were more prevalent amongst 66-years and above (19.36% vs. 45-64 years: 6.81% vs. 18-44 years: 1.17%), male (10.40% vs. female: 5.66%), Non-Hispanic White race (10.92%), and lower annual household income population (<$25000 vs. >$100,000:12.21% vs. 4.01%) (p<0.0001). When compared with respondents without a history of CVDs, respondents with a history of CVDs were noted to be more prevalent with a concurrent diagnosis of hypertension (85.98% vs. 79.53%), hypercholesterolemia (68.78% vs. 34.54%), diabetes (37.86% vs. 12.70%), stroke (17.4% vs. 2.71%), and congestive heart failure (28.80% vs. 1.31%) (p<0.0001). History of CVDs were more prevalent amongst the respondents using marijuana (overall 53.14%; CVD vs. no-CVD 65.42% vs. 52.81%; p<0.0001), cigarette smoking (60.47% vs. 40.41%; p<0.0001), cigar-smoking (47.05% vs. 35.58%; p<0.0001), methamphetamine/cocaine/heroin (23.82% vs. 16.71%; p<0.0001), smokeless tobacco use (18.53% vs. 14.59%; p<0.0001), and injectable illegal drug use (4.67% vs. 2.43%; p<0.0001). Additionally, prevalence of history of CVDs was almost double in respondents using cigarettes without filters (2.28% vs. 1.10%; p<0.0001) when compared with respondents using cigarettes with filters.
Respondents who used marijuana or hashish, injectable illegal drugs, and e-cigars were at elevated risk for cardiovascular disorders. Providing situational awareness and offering a good support system can be a strategy to prevent the development of cardiovascular disorders among substance users.
物质使用障碍(SUDs)被认为是心血管疾病(CVDs)的主要危险因素。2019年,根据全国药物使用和健康调查(NSDUH),2040万美国成年人患有物质使用障碍。本研究的主要目的是确定在诊断患有各种心血管疾病(心绞痛、心肌梗死和冠心病)的患者中,几种物质使用障碍(吸烟、抽雪茄、使用无烟烟草、吸食大麻、使用可卡因/海洛因/甲基苯丙胺以及注射非法药物)的患病率。
这是一项回顾性横断面研究,使用了2013年至2018年的国家健康和营养检查调查(NHANES)数据库,通过问卷识别出患有心血管疾病的受访者。在有心血管疾病病史和无心血管疾病病史的成年人群中确定了不同的物质使用障碍(既往史)。使用卡方检验和非配对t检验/曼-惠特尼检验进行单因素分析,以确定患有心血管疾病的受访者的特征,并生成混合效应多变量逻辑回归模型,以找出心血管疾病人群中物质使用障碍的患病率。使用统计分析系统(SAS)软件对数据集进行分析,p值<0.05被认为具有统计学意义。
在263465名受访者中,7.90%的受访者被诊断患有心血管疾病,且被发现年龄较大(中位年龄:69岁)。心血管疾病在66岁及以上人群中更为普遍(19.36%,而45 - 64岁人群为6.81%,18 - 44岁人群为1.17%),男性(10.40%,女性为5.66%),非西班牙裔白人(10.92%)以及家庭年收入较低人群(<$25000,而>$100000人群为12.21%对4.01%)(p<0.0001)。与无心血管疾病病史的受访者相比,有心血管疾病病史的受访者同时诊断患有高血压(85.98%对79.53%)、高胆固醇血症(68.78%对34.54%)、糖尿病(37.86%对12.70%)、中风(17.4%对2.71%)和充血性心力衰竭(28.80%对1.31%)的情况更为普遍(p<0.0001)。心血管疾病病史在吸食大麻的受访者中更为普遍(总体为53.14%;有心血管疾病与无心血管疾病者分别为65.42%对52.81%;p<0.0001)、吸烟(60.47%对40.41%;p<0.0001)、抽雪茄(47.05%对35.58%;p<0.0001)、使用甲基苯丙胺/可卡因/海洛因(23.82%对16.71%;p<0.0001)、使用无烟烟草(18.53%对14.59%;p<0.0001)以及注射非法药物(4.67%对2.43%;p<0.0001)的受访者中更为普遍。此外,与使用有过滤嘴香烟的受访者相比,使用无过滤嘴香烟的受访者中有心血管疾病病史的患病率几乎翻倍(2.28%对1.10%;p<0.0001)。
使用大麻或哈希什、注射非法药物以及使用电子烟的受访者患心血管疾病的风险更高。提供情景意识并提供良好的支持系统可能是预防物质使用者发生心血管疾病的一种策略。